Randomized trial demonstrates the potential of cryo-electron tomography for drug discovery and disease insights, suggesting significant advancements in structural biology.
Cryo-electron tomography (cryo-ET) is emerging as a transformative tool for structural biology. Unlike methods based on purified molecules, cryo-ET enables visualisation of macromolecules directly within intact cells and tissues, preserving their native interactions and physiological context. By providing high-resolution views of healthy and diseased cells, cryo-ET offers a powerful means to understand infection and disease mechanisms. Moreover, cryo-ET combined with subtomogram averaging can resolve macromolecular structures beyond 3 Å resolution, making it a promising approach for computational drug discovery. This article highlights the recent contributions from cryo-ET in understanding human disease and examines future perspectives of this rapidly evolving technique in structure-based drug discovery. We propose a roadmap for the developments required for its widespread adoption in pharmacological research.
No takes yet. Share an insight, caveat, or question.
Clemente et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: